These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33206753)

  • 1. Anti-Helicobacter pylori treatment can effectively improve the clinical remission rates of irritable bowel syndrome: a controlled clinical trial meta-analysis.
    Xiong Y; Liu L; Zhou X; Wen Y; Wang R
    Clinics (Sao Paulo); 2020; 75():e1857. PubMed ID: 33206753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is there an association between
    Ng QX; Foo NX; Loke W; Koh YQ; Seah VJM; Soh AYS; Yeo WS
    World J Gastroenterol; 2019 Oct; 25(37):5702-5710. PubMed ID: 31602169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between Helicobacter pylori infection and irritable bowel syndrome: a systematic review and meta-analysis.
    Wang C; Yin Y; Wang L; Guo X; Liu L; Qi X
    Postgrad Med J; 2023 May; 99(1169):166-175. PubMed ID: 37222050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Association between
    Kim YA; Cho YJ; Kwak SG
    Int J Environ Res Public Health; 2020 Apr; 17(7):. PubMed ID: 32272678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between Helicobacter pylori infection and irritable bowel syndrome: A systematic review and meta-analysis.
    Li C; Shuai Y; Zhou X; Chen H
    Medicine (Baltimore); 2020 Dec; 99(50):e22975. PubMed ID: 33327230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between Helicobacter pylori infection and irritable bowel syndrome: a systematic review and meta-analysis.
    Wang C; Yin Y; Wang L; Guo X; Liu L; Qi X
    Postgrad Med J; 2021 Dec; ():. PubMed ID: 37068773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk for Irritable Bowel Syndrome in Patients with Helicobacter Pylori Infection: A Nationwide Population-Based Study Cohort Study in Taiwan.
    Liang CM; Hsu CH; Chung CH; Chen CY; Wang LY; Hsu SD; Chang PK; Hong ZJ; Chien WC; Hu JM
    Int J Environ Res Public Health; 2020 May; 17(10):. PubMed ID: 32466223
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Wang Z; Liu Y; Peng Y; Peng L
    Medicina (Kaunas); 2022 Aug; 58(8):. PubMed ID: 36013502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials.
    Rahimi R; Nikfar S; Abdollahi M
    Clin Ther; 2008 May; 30(5):884-901. PubMed ID: 18555935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blastocystis subtypes isolated from irritable bowel syndrome patients and co-infection with Helicobacter pylori.
    El-Badry AA; Abd El Wahab WM; Hamdy DA; Aboud A
    Parasitol Res; 2018 Jan; 117(1):127-137. PubMed ID: 29138961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy and safety of rifaximin for the irritable bowel syndrome: a systematic review and meta-analysis.
    Menees SB; Maneerattannaporn M; Kim HM; Chey WD
    Am J Gastroenterol; 2012 Jan; 107(1):28-35; quiz 36. PubMed ID: 22045120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tegaserod for the treatment of irritable bowel syndrome and chronic constipation.
    Evans BW; Clark WK; Moore DJ; Whorwell PJ
    Cochrane Database Syst Rev; 2007 Oct; (4):CD003960. PubMed ID: 17943807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biofeedback for treatment of irritable bowel syndrome.
    Goldenberg JZ; Brignall M; Hamilton M; Beardsley J; Batson RD; Hawrelak J; Lichtenstein B; Johnston BC
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31713856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Probiotic Supplementation Therapy for Helicobacter pylori Eradication: A Meta-Analysis of Randomized Controlled Trials.
    Lü M; Yu S; Deng J; Yan Q; Yang C; Xia G; Zhou X
    PLoS One; 2016; 11(10):e0163743. PubMed ID: 27723762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoroquinolone Sequential Therapy for Helicobacter pylori: A Meta-analysis.
    Kale-Pradhan PB; Mihaescu A; Wilhelm SM
    Pharmacotherapy; 2015 Aug; 35(8):719-30. PubMed ID: 26173786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ASSOCIATION BETWEEN H. PYLORI INFECTION AND IRRITABLE BOWEL SYNDROME.
    Hamad AJ; Alnaji EK; Almohana SJ; Kareem YS; Albdairi AJ
    Wiad Lek; 2023; 76(2):406-414. PubMed ID: 37010180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tegaserod for the treatment of irritable bowel syndrome.
    Evans BW; Clark WK; Moore DJ; Whorwell PJ
    Cochrane Database Syst Rev; 2004; (1):CD003960. PubMed ID: 14974049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of randomized controlled trials on the efficacy of probiotics in Helicobacter pylori eradication therapy in children.
    Li S; Huang XL; Sui JZ; Chen SY; Xie YT; Deng Y; Wang J; Xie L; Li TJ; He Y; Peng QL; Qin X; Zeng ZY
    Eur J Pediatr; 2014 Feb; 173(2):153-61. PubMed ID: 24323343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of adjuvant N acetyl cysteine for the eradication of H pylori infections: A systematic review and meta-analysis of randomized clinical trials.
    Biswas DP; Tk DS
    Clin Res Hepatol Gastroenterol; 2022 Mar; 46(3):101832. PubMed ID: 34775122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic review: probiotics in the management of lower gastrointestinal symptoms - an updated evidence-based international consensus.
    Hungin APS; Mitchell CR; Whorwell P; Mulligan C; Cole O; Agréus L; Fracasso P; Lionis C; Mendive J; Philippart de Foy JM; Seifert B; Wensaas KA; Winchester C; de Wit N;
    Aliment Pharmacol Ther; 2018 Apr; 47(8):1054-1070. PubMed ID: 29460487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.